151 related articles for article (PubMed ID: 16476927)
1. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry.
Deng YZ; Reeves MJ; Jacobs BS; Birbeck GL; Kothari RU; Hickenbottom SL; Mullard AJ; Wehner S; Maddox K; Majid A;
Neurology; 2006 Feb; 66(3):306-12. PubMed ID: 16476927
[TBL] [Abstract][Full Text] [Related]
2. Why are eligible thrombolysis candidates left untreated?
Hills NK; Johnston SC
Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305
[TBL] [Abstract][Full Text] [Related]
3. The number of stroke physicians is the key to preparing IV rt-PA.
Iguchi Y; Kimura K; Shibazaki K; Aoki J
Cerebrovasc Dis; 2009; 28(5):460-7. PubMed ID: 19738375
[TBL] [Abstract][Full Text] [Related]
4. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
[TBL] [Abstract][Full Text] [Related]
5. The Paul Coverdell National Acute Stroke Registry: initial results from four prototypes.
Reeves MJ; Broderick JP; Frankel M; LaBresh KA; Schwamm L; Moomaw CJ; Weiss P; Katzan I; ; Arora S; Heinrich JP; Hickenbottom S; Karp H; Malarcher A; Mensah G; Reeves MJ
Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S202-9. PubMed ID: 17178304
[TBL] [Abstract][Full Text] [Related]
6. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.
California Acute Stroke Pilot Registry (CASPR) Investigators
Neurology; 2005 Feb; 64(4):654-9. PubMed ID: 15728287
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator use: evaluation and initial management of ischemic stroke from an Iowa hospital perspective.
Albright KC; Schott TC; Jafari N; Wohlford-Wessels MP; Finnerty EP; Jacoby MR
J Stroke Cerebrovasc Dis; 2005; 14(3):127-35. PubMed ID: 17904012
[TBL] [Abstract][Full Text] [Related]
8. [Prospects of thrombolytic therapy for acute ischemic stroke].
Nakashima T; Minematsu K
Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
[TBL] [Abstract][Full Text] [Related]
9. The "drip-and-ship" approach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center.
Silverman IE; Beland DK; Chhabra J; McCullough LD
Conn Med; 2005; 69(10):613-20. PubMed ID: 16381108
[TBL] [Abstract][Full Text] [Related]
10. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
[TBL] [Abstract][Full Text] [Related]
11. Prehospital and hospital delays after stroke onset--United States, 2005-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 May; 56(19):474-8. PubMed ID: 17510611
[TBL] [Abstract][Full Text] [Related]
12. Pre-hospital delay in the use of intravenous rt-PA for acute ischemic stroke in Japan.
Inatomi Y; Yonehara T; Hashimoto Y; Hirano T; Uchino M
J Neurol Sci; 2008 Jul; 270(1-2):127-32. PubMed ID: 18395754
[TBL] [Abstract][Full Text] [Related]
13. The impact of lesion side on acute stroke treatment.
Di Legge S; Fang J; Saposnik G; Hachinski V
Neurology; 2005 Jul; 65(1):81-6. PubMed ID: 16009890
[TBL] [Abstract][Full Text] [Related]
14. Increasing number of stroke specialists should contribute to utilization of IV rt-PA: results of questionnaires from 1,466 hospitals in Japan.
Iguchi Y; Kimura K; Shibazaki K; Iwanaga T
J Neurol Sci; 2009 Apr; 279(1-2):66-9. PubMed ID: 19185882
[TBL] [Abstract][Full Text] [Related]
15. Advance hospital notification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator.
Abdullah AR; Smith EE; Biddinger PD; Kalenderian D; Schwamm LH
Prehosp Emerg Care; 2008; 12(4):426-31. PubMed ID: 18924004
[TBL] [Abstract][Full Text] [Related]
16. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry.
Reid JM; Gubitz GJ; Phillips SJ
Neurology; 2006 Nov; 67(9):1724-5; author reply 1724-5. PubMed ID: 17101926
[No Abstract] [Full Text] [Related]
17. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study.
Saqqur M; Tsivgoulis G; Molina CA; Demchuk AM; Siddiqui M; Alvarez-Sabín J; Uchino K; Calleja S; Alexandrov AV;
Neurology; 2008 Oct; 71(17):1304-12. PubMed ID: 18753474
[TBL] [Abstract][Full Text] [Related]
19. Trombolysis in acute stroke.
Schwammenthal Y; Tsabari R; Bakon M; Orion D; Merzeliak O; Tanne D
Isr Med Assoc J; 2006 Nov; 8(11):784-7. PubMed ID: 17180831
[TBL] [Abstract][Full Text] [Related]
20. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].
García-García J; Gracia-Gil J; Sopelana-Garay D; Ayo-Martín O; Vadillo-Bermejo A; Touza B; Peñalver-Pardines C; Zorita MD; Segura T
Rev Neurol; 2008 Jan 1-15; 46(1):7-12. PubMed ID: 18214820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
